New Pain Relief Gel Shows Promising Results in Clinical Trials
A Swedish pharmaceutical company, AlzeCure Pharma, has shared exciting new results from a clinical trial of its pain-relief gel, ACD440, […]
Browsing category
A Swedish pharmaceutical company, AlzeCure Pharma, has shared exciting new results from a clinical trial of its pain-relief gel, ACD440, […]
The FDA has approved updated COVID-19 vaccines from Pfizer, Moderna, and Novavax, but only for people at higher risk of […]
Two experienced drug developers, Josh Bilenker and Jeff Engelman, have been working in secret for years on a new biotech […]
A new report from the World Health Organization (WHO) reveals that over one billion people worldwide suffer from mental health […]
A new treatment for severe liver disease is being tested in humans for the first time. Resolution Therapeutics has started […]
A new experimental RNA therapy from Wave Life Sciences has shown potential in helping patients with a rare genetic disorder […]
Astellas and Apellis are two companies competing in the U.S. to treat geographic atrophy (GA), a serious eye condition that […]
Earlier this year, EyePoint Pharmaceuticals faced setbacks when their drug-device combination, Duravyu, did not perform well in a study for […]
Here’s a simplified version of the text: **Key People at IQVIA** – Nancy McGee: VP of U.S. Patient Support Services […]
Welcome to Fierce Pharma’s 2024 regulatory tracker. We’re keeping track of the approval progress for pharmaceutical products, including their expansion […]